Background/Aims: The hyperpolarization-activated cyclic nucleotide-gated cation channel HCN4 contributes significantly to the generation of basic cardiac electrical activity in the sinus node and is a mediator of modulation by β-adrenergic stimulation. Heterologous expression of sick sinus syndrome (SSS) and bradycardia associated mutations within the human HCN4 gene results in altered channel function. The main aim was to describe the functional characterization of three (two novel and one known) missense mutations of HCN4 identified in families with SSS. Methods: Here, the two-electrode voltage clamp technique on Xenopus laevis oocytes and confocal imaging on transfected COS7 cells respectively, were used to analyze the functional effects of three HCN4 mutations; R378C, R550H, and E1193Q. Membrane surface expressions of wild type and the mutant channels were assessed by confocal microscopy, chemiluminescence assay, and Western blot in COS7 and HeLa cells. Results: The homomeric mutant channels R550H and E1193Q showed loss of function through increased rates of deactivation and distinctly reduced surface expression in all three homomeric mutant channels. HCN4 channels containing R550H and E1193Q mutant subunits only showed minor effects on the voltage dependence and rates of activation/deactivation. In contrast, homomeric R378C exerted a left-shifted activation curve and slowed activation kinetics. These effects were reduced in heteromeric co-expression of R378C with wild-type
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Introduction
The heart beats with astonishing precision throughout human life. During this period, it is adapted to stress situations that increase the rate (positive chronotropic), and pump load (positive inotropic). The sino-atrial node (SAN) is a primary controller of cardiac rhythmicity. It initially develops from a portion of the pro-pacemaking embryonic venous pole under the influence of early canonical Wnt pathway. The adult node is a mixture of distinct cardiomyocytes located at the orifice of the right superior vena cava (SVC) into the right atrium [1] . The cells of the SAN do not reach stable resting membrane potential but show rhythmic activity generated in part by the depolarizing hyperpolarization activated current I f (I f -funny current, also named I h -hyperpolarization activated current or I q = queer current) [2] . This current is generated by the hyperpolarization-activated cyclic nucleotidegated channels of the HCN family. There are four members of this channel family, HCN1-4 which can assemble in native tissues as homo-or hetero-tetramers. The most prominent HCN channel in the human sinus node is HCN4 which may be associated with KCNE2 (MiRP1 -MinK-related peptide-1), a putative β-subunit of HCN4, in the SAN [1, 2] . Cyclic AMP (cAMP) is generated in response to stress-associated β-adrenergic stimulation, which then binds to the cyclic nucleotide binding site of HCN4 channels. The binding of cAMP induces conformational HCN4 changes leading to a rightward shift in the steady-state activation curve [3] . The channel becomes more sensitive to hyperpolarizing voltages resulting in the depolarization of SAN cells and faster cardiac rhythm. Impaired pacemaking of the SAN is referred to as sick sinus syndrome (SSS) [3] . SSS is clinically characterized by bradycardia and a combination of symptoms such as fatigue, dizziness, and syncope. It is an inability of the SAN to transmit its activity to the atrium or to generate the intrinsic electrical automaticity [4] . In 2003, familial SSS was linked to inherited mutations in the HCN gene family [5] . Later, the HCN4 locus was identified as a modulator of heart rate in a genome-wide association study (GWAS) [6] . Down-regulation of HCN4 and the subsequent reduction in heart rate has been reported as the mechanism of lowering the resting heart rate associated with endurance exercise [7] . Transgenic mice deficient in HCN1 [8] , and HCN2 [9] manifest SSS. In humans, mutations modifying I f functions are exclusively limited to HCN4 and rarely to KCNE2 [5, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Recently, epilepsy-related premature mortality and restrictive cardiomyopathy have been genetically associated with HCN4 mutations [21, 22] .
Electrophysiological experiments on heterologously expressed WT and mutant HCN4 channels showed changes in protein trafficking, channel gating, and/or cAMP-sensitivity as the disease mechanism [21] . Here, we described the functional characterization of three (two novel and one known) missense mutations of HCN4 identified in families with SSS.
Materials and Methods

Mutation identification
Genomic DNA was extracted from the peripheral lymphocytes of the patients and family members using standard techniques and the HCN4 gene was sequenced as previously described [5] .
Molecular biology
These procedures were as previously described [22] . Human HCN4 was subcloned into the Xenopus laevis Stage V oocyte expression vector pSGEM. The clones were mutated at positions R378C, R550H, and E1193Q by site-directed mutagenesis using QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). All constructs were confirmed by automated DNA sequencing. The constructs were Peak tail current analysis at a potential of -140 mV after varying test pulses was used to assess the voltage dependence of the HCN4 channel activation. These peak currents were fitted to the standard Boltzmann equation to calculate the voltage dependence of activation.
, to obtain the voltage required for half-maximal activation (V 1⁄2 ), slope factor (k), and the minimum open probability (min-Po, defined as the minimum value of relative tail current [23] .
HCN4 channel activation and deactivation was analyzed by fitting activating inward currents or the upward reflection upon deactivating pulses to an exponential equation of the form: I(t)= a exp(-t/t) + a 0 , with a fast time constant, t; their respective amplitudes, a; and an offset current, a 0 .
Confocal microscopy, chemiluminescence assay, and Western blot in mammalian cells
Cells were cultivated in petri dishes at 37 °C and 5% CO 2 in DMEM medium + 10% FBS and 1% MEM Non-essential amino acid (Sigma-Aldrich). During culturing, cells were carefully washed in 10 ml PBS (Sigma-Aldrich) prior to the addition of new culture medium. COS7 cells were then transfected with the HA-EGFP-HCN4 construct (1 μg HCN4 cDNA), [24] and in the case of confocal microscopic experiments, additional 0.5 μg ER-Marker cDNA using jetPRIME (Peqlab) was transfected. Chemiluminescence assay: HeLa cells were transfected with the HA-EGFP-HCN4 construct (1 μg HCN4 cDNA). This assay was performed as previously described [25] : After 48 h, HeLa cells were fixed with 4% PFA (in PBS), washed three times with PBS, and blocked with 10% normal goat serum (in PBS supplemented with 0.1% sodium azide). Cells were stained with a monoclonal anti-HA primary antibody (HA probe (F-7), Santa Cruz Biotechnology) and washed intensely with PBS. As a secondary antibody, an HRP-conjugated antibody (goat anti-mouse IgG-HRP, Santa Cruz Biotechnology) was used. After several washing steps with PBS, surface expression was measured in a luminometer (Glomax 20/20, Promega) using a luminogenic substrate (SuperSignal ELISA Femto, Pierce Biotechnology). Western blot analysis: Protein lysates were separated on a SDS-polyacrylamide gel and transferred to a nitrocellulose membrane via a Semi-Dry Transfer Cell (Biorad). HA-EGFP-HCN4 protein was visualized by immunoblotting with mouse anti-GFP antibody (ab290, 1:5000, Abcam). The binding of the primary antibody was detected using peroxidase-conjugated goat anti-rabbit IgG antibody (#32460, 1:2000, Pierce Thermo Scientific) and a chemiluminescent extended-duration substrate (Super Signal West Dura, Thermo Scientific).
Confocal microscopy: COS7 cells were fixed with 4% PFA (in PBS), washed three times with PBS, and blocked with 10% normal goat serum (in PBS supplemented with 0.1% sodium azide). Cells were incubated for 1 h in monoclonal anti-HA primary antibody (HA probe (F-7), Santa Cruz Biotechnology), washed three times in PBS and stained with secondary dye-conjugated antibody (Alexa Fluor® 594 Dye, 1:200) in 5% goat serum in PBS. Prior to fixation, the cells were washed three times in PBS and embedded in Fluoromount™ (Sigma-Aldrich). Confocal microscopy was performed using a DMI4000B (Leica) microscope with a 40x objective (HCX PL FLUOTAR 40.0×0.75), excitation was at 488 nm, and fluorescence was detected between 550 and 594 nm. Data was analyzed using ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA). Line scans were used to analyze the total HCN4. 
Molecular modeling
A consensus homology HCN4 model was generated. Several individual modeling steps using YASARA Structure version 10.1 were required. The HCN4 pore domain was generated as a consensus model using a modelling protocol as previously described [26] . This pore domain was fused to a HCN4-C-terminal consensus model using the same protocol. The resultant model represented one human HCN4-subunit covering residues 249 -734. A tetrameric channel HCN4 model was generated by combining four virtual identical subunits in a 4-fold symmetry. The resulting tetrameric model was energy minimized using the YASARA Structure Module Energy Minimization Server. By swapping residues R378 to cys or R550 to his, mutant channels were generated. WT and mutant channel models were incorporated into membranes and short molecular dynamics (MD) simulations (5 ns) were performed as previously described [27] . Only local structural changes were noted at the end of the simulations when comparing the WT channels structure with those of the mutant channels.
Statistical analyses
These were performed using unpaired t-test and one-way-ANOVA. Data was presented as mean values, and error bars indicated SEM. Significance levels of the test showing p-values were indicated by stars as follows: * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
Results
Identification of the three HCN4 gene mutations in patients
Over the years, patients with clinical manifestations of SSS were identified through the outpatient service; they all exhibited substantially reduced heart rate lower than 60 beats per minute at rest after the exclusion of secondary causes. The classical candidate gene for SSS is the HCN4 gene [5] . In summary, a genetic analysis of the complete HCN4 gene in 57 unrelated probands with idiopathic or familial SSS was performed, among them, three nucleotide variants resulting in non-synonymous amino acid exchanges were found. Two (HCN4-R378C, and HCN4-R550H) were novel, whereas HCN4-E1193Q had been recently published in a proband with early-onset atrial fibrillation, Brugada syndrome, with epilepsy, and with restrictive cardiomyopathy [12] . The mutations were positioned in the transmembrane domain (HCN4-R378C) or in the intracellular C-terminus (HCN4-R550H and HCN4-E1193Q), (Fig. 1A) .
In a female proband with childhood onset of SSS, the heterozygous nucleotide and concordantly predicted to be "deleterious" by several mutation pathogenicity tools (SIFT, Mutation taster, and PolyPhen-2).
The novel nonsynonymous amino acid exchange p.Arg550His (shortened as: R550H) (FID 11079) (c.1649G>A) was heterozygously identified in a female proband with asymptomatic sinus bradycardia and ventricular extrasystoles (VES). Its characteristics include extreme rarity in the ExAC database and "deleterious" prediction by the mutation pathogenicity tools, as well as high degree of evolutionary conservation of arginine at position 550 throughout the HCN4 orthologs.
Finally, we identified a heterozygous nucleotide transversion c.3577G>C (resulting in the non-synonymous amino acid exchange p.Glu1193Gln, shortened as: E1193Q) in a 22-year-old female proband with symptomatic SSS. Her clinical symptoms included recurrent syncope with first manifestation at age of 14. The mutation was also identified in three other family members (FID 11034). The low-frequency variant, E1193Q was recently described as a pathogenic mutation in a patient with early-onset atrial fibrillation, but it exists in control population databases such as the Exome Variant Server (MAF: 0.02%) or ExAC (MAF: 0.099%), raising its functional impact.
Since all three HCN4 variants had not been reported before in the context of SSS, we analyzed their functional effects to further support the potential disease-causing mutations notion.
Novel HCN4 mutations reduced function in heterologous expression systems
To assess the functional consequences of the HCN4 mutations, we analyzed the homoand hetero-meric mutant channels in heterologous expression systems. Homomeric expression of native HCN4 (HCN4-WT) in Xenopus laevis oocytes resulted in classical hyperpolarization-activated channel currents (Fig. 2) . In all the cases, expression of mutant HCN4 channels resulted in decreased, but fully-activated currents compared to HCN4-WT. Specifically, R378C reduced HCN4-mediated currents by 70% (homomeric state), and 57% (heteromeric), R550H reduced currents by 49% (homomeric), and 29% (heteromeric), while E1193Q reduced currents by 52% (homomeric) and 49% (heteromeric), respectively. 
HCN4-WT
and mutant HCN4 channels were expressed in Xenopus laevis oocytes, currents were elicited by 3 s hyperpolarizing pulses in 10 mV increments ranging from -140 to -30 mV (holding potential = 0 mV, tail potential = -130 mV). Currents were analyzed at the end of 3 s hyperpolarizing pulses and were normalized to their respective WT values. RepresentativeCellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2018 The Author(s). Published by S. Karger AG, Basel www.karger.com/cpb Möller et al.: Novel HCN4 Mutations
Novel HCN4 mutations altered biophysical behaviour of mutant channels in heterologous expression systems
It has been reported that some human HCN4 mutations cause altered HCN4 channel biophysical behavior [21] . We analyzed voltage-dependence and found an extensive significant left-shifted V 1/2 for the R378C mutant (V 1/2 -shift = -32.5 mV, R378C/WT: V 1/2 -shift = -7.9 mV, Fig. 3 ). Time constants of activation τ act were increased in R378C and deactivation τ deact were decreased in most homo-and hetero-meric mutant channels compared to those of WT (Fig. 4) . Notably, the slowing of the mutant channel activation in case of E1193Q only occurred outside the physiological range of membrane potentials.
Novel HCN4 mutations reduced channel plasma membrane expression in heterologous expression systems Reduced channel surface expression is often seen in diseases associated with ion channels. Here, we used HCN4 clones with an external HA-tag and an internal EGFP as previously described [24] . WT and mutant channels were expressed in HeLa cells using the external HA-tag to detect the proteins at the plasma membrane by a chemiluminescence assay. Plasma membrane abundance of all three mutant channels was significantly diminished (Fig. 5A) . Western blot analyses of the cells detecting the N-terminal EGFP-tag showed decreased protein expression, indicating that the mutant HCN4 channels had impaired protein stability due to their respective mutations (Fig. 5A ). This effect was particularly evident for the HCN4-E1193Q mutant. Reduced plasma membrane expression of mutant HCN4 channels possibly resulted from altered subcellular localization, in addition to the reduced total HCN4 protein expression. Thus, to test the altered subcellular localization, WT and mutant channels were expressed in COS7 cells and the external HA-tag was used for immunostaining. Line plots of the EGFP and red antibody fluorescence generated information on plasma membrane expressed HCN4 channels as well as those throughout the cell. The ratio between the peak membrane EGFP intensity and the mean EGFP intensity was calculated to estimate the relative membrane expression of WT and mutant channels. The resulting relative plasma membrane abundance of mutant HCN4 channels were reduced similar to those of the biotinylation Western blot results (Fig. 5) . Inverted ratios (increased channel protein intracellular vs. channel protein at the plasma membrane) were found with HCN4-R378C and HCN4-E1193Q, suggesting trafficking defects in mutant HCN4 channels. Trafficking defects of ion channels are often associated with time-dependent channel endocytosis from the cell membrane. We, therefore expressed WT and mutant HCN4 channels in Xenopus laevis oocytes and recorded current amplitudes 3 -6 days after cRNA injections. Whereas functional expression of HCN4-WT increased during this period, mutant channels tend to showed decreased function on day 6. This effect seemed to be more prominent in HCN4-R378C and HCN4-R550H than in HCN4-E1193Q, suggesting reduced protein stability (Fig. 6) . 
The novel HCN4 mutations possibly altered structural features of mutant channels as suggested by in silico modelling
The mutations reported here were localized in different regions spanning from the transmembrane domain to the end of the C-terminus (Fig. 1A) . Kinetic phenotypes were relatively variable as well. However, they all showed physiologically reduced plasma membrane expression. To understand the structural basis of channel dysfunction and altered localizations, homology modeling was performed, followed by molecular dynamics (MD) simulations on WT and mutant channels which were run in parallel and the dynamic characteristics compared on a small-time scale. High-resolution consensus homology modeling was possible for residues 249 -734. Therefore, only altered residues R378C and R550H could be modelled. We found that R378C and R550H were localized to the center of the voltage sensor and gating ring domains, respectively (Fig. 7) . R378C may have contact with the outer pore domain of the adjacent subunit (within 5Å-LEU 438: 92 contacts, GLN 443 : 83 contacts, ASP 444 : 46 contacts, VAL 439 : 40 contacts, PHE 445 : 1 contact), whereas R550H was in contact with the cAMP binding domain within one subunit (within 5Å-GLN 617 : 128 contacts, PRO 618 : 29 contacts, ASP 620 : 28 contacts, GLY 619 : 14 contacts, TYR 678 : 1 contact). In silico simulation suggests that the R378C and R550H contacts may have been affected by the diseaseassociated mutations. However, the precise changes were local and did not affect the rest of the modelled protein structure. This may have been due to the relatively short simulation duration, as only extremely cost intensive long-range simulations within microseconds could uncover global changes. In summary, mutant HCN4 channels showed reduced function in the heterologous expression systems. Besides variable kinetic effects, all mutant channels exerted reduced cell surface expressions which may be the main reason for the loss of function in the mutant channels leading to SSS.
Discussion
Bradycardia is a major cause of cardiac arrhythmias and sudden cardiac death. Mostly, it results from the reduced rhythmic activity of the sinus node rather than as a developmental defect. Determinants of spontaneous diastolic depolarization and rhythmic (pacemaking) activity of the human sinus node are the hyperpolarization-activated current I f (mediated is shown in volume-fill and CPK coloring. 
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by HCN4 channels) and the inward calcium currents. Consequently, reduced HCN4 function results in decreased rate of sinus node activity. Reduced HCN4 function has been reported for several familial HCN4 mutations associated with bradycardia in SSS [21] . Furthermore, reduced I f function in the human sinus node action potentials leads to bradycardia which can be calculated in silico using a recently developed sinus node model [28] . Consistently, we three rare HCN4 gene variants in four SSS patients. These gene variants were clearly inherited in the cases of HCN4-R378C and HCN4-E1193Q as the gene trees showed normal inheritance with 3 -4 family members carrying the variant (Fig. 1B) . Due to lack of clinical data in case of the E1193Q mutation and the R550H mutation, it is unclear whether the genetically affected family members also show sinus bradycardia. As HCN4 gene mutations potentially cause reduced I f function and sinus node rhythmicity, in vitro experiments were used to assay the identified gene variants. Significantly reduced fully-activated current in all three gene variants were found (Fig. 2) . Kinetic analysis of activation showed greater left-shifted activation for homomeric R378C and to less extent for heteromeric R378C/WT complexes (Fig. 3) . Residue 378 is positioned in the S4 transmembrane segment (the primary voltage sensor), thus, the shift in voltage dependence was conceivable. Positively-charged arginines in the S4 segment of HCN channels allow for the inverted opening of HCN channels compared to those of the prototypic Kv [23] . Thus, the positively-charged R378C mutated in the patient increased the apparent voltage sensation by charge neutralization effect. Activation of mutants R378C and R550H tend to be slowed down at -60 mV, while deactivation at 20 mV of all three mutants show a trend to get accelerated (Fig. 4) . Data was consistent with destabilization of the channels open state, an effect that shifts the fraction of channels towards the closed state resulting in reduced number of active channels at the plasma membrane.
Aside from kinetic effects, channel function was determined by the channel abundance at the plasma membrane. All three mutations led to reduced plasma membrane abundance as assayed by Western blot, chemiluminescence, and confocal imaging (Fig. 5) . In WT channels, protein density at the plasma membrane was increased compared to that of intracellular protein. In mutant channels, the intracellular protein levels were comparable to that of WT. However, in general less plasma membrane protein was observed in mutant channels compared to WT (Fig. 5) . Furthermore, time-dependent reduction of mutant HCN4 channel currents suggests altered trafficking, and possibly increased endocytosis (Fig. 6) . These results show that altered trafficking e.g. decreased exocytosis or increased endocytosis of mutant HCN4 leads to decreased channel surface expression and reduced channel function in vitro. E1193Q mutation in association with Brugada syndrome has also been reported [29] . Macri et al. found an association between HCN4-E1193Q mutation and atrial fibrillation and patch clamp experiments were used to assess the mutation-induced changes in channel properties [12] . Their study found a mild but insignificant shift in the V 1/2 which is consistent with our results. Further, HCN4-E1193Q mutation was associated with epilepsy and restrictive cardiomyopathy [21, 22] [21, 22] . In the present study, there was no association between this mutation and Brugada syndrome, atrial fibrillation, epilepsy or restrictive cardiomyopathy. Possibly, the HCN4-E1193Q mutation is a genetic modifier of the other clinical entities reported earlier as well as a mutation that causes clear functional alterations in HCN4 [21, 22] .
Homology modeling of HCN4 channels showed that R378 interacts with the pore domain of the adjacent HCN4 subunit. R550 within the gating ring is in contact with the cAMP binding domain. Thus, both residues are present at the interface of the two channel domains in an in-silico model and mutations at these sites alter inter-domain assembly. Probably, such altered domain-domain interactions cause protein misfolding which decrease protein stability within the cellular context.
Here, we identified the mild kinetic effects and the markedly reduced plasma membrane abundance as the major causes of the mutant HCN4 channel dysfunction. The moderate Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry hyperpolarizing shift in half-activation voltage of R378C+WT (shift compared to WT -7.9 ± 2.1 mV) is slightly larger compared to the less prominent shift in HCN4-573X and HCN4-695X reported with SSS [5, 17] . However, the loss of function in HCN4-R378C resulted from the reduced surface expression rather than impaired cAMP modulation, which caused functional impairments in HCN4-573X or HCN4-695X. Notably, none of the three mutations analyzed here had dramatic impairments in cAMP activation as the injection of cAMP led to inestimable degree activation of WT and mutant currents, (data not shown). HCN4-R550H is positioned in close proximity to the reported HCN4-D553N mutation. As opposed to HCN4-R550H, D553N caused loss of function mainly due to the defective C-linker mediated gating ring and trafficking [24] . In summary, we analyzed three HCN4 mutations identified in index patients that caused loss of function in vitro. Loss of function may have resulted from significantly reduced functional HCN4 channel availability and cell surface expression due to defective trafficking.
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